CytoDyn: CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025

CytoDyn Inc. reported earnings results for the third quarter and nine months ended February 28, 2025. For the third quarter, the company reported net loss was USD 4.76 million compared to USD 11.92 million a year ago. For the nine months, net income was USD 9.7 million compared to net loss of USD 33.05 million a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to basic loss per share from continuing operations of USD 0.04 a year ago. Diluted earnings per share from continuing operations was USD 0.01 compared to diluted loss per share from continuing operations of USD 0.04 a year ago.